Guardant Health Note 11/1 (Principal)
|
6.3 |
$193M |
|
268M |
0.72 |
Exact Sciences Corp Note 0.375% 3/0 (Principal)
|
4.4 |
$135M |
|
131M |
1.03 |
Novocure Note 11/0 (Principal)
|
3.9 |
$118M |
|
136M |
0.87 |
Nanostring Technologies Note 2.625% 3/0 (Principal)
|
3.8 |
$115M |
|
146M |
0.79 |
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
|
3.7 |
$113M |
|
124M |
0.91 |
Bridgebio Pharma Note 2.500% 3/1 (Principal)
|
3.3 |
$101M |
|
128M |
0.79 |
Nevro Corp Note 2.750% 4/0 (Principal)
|
3.3 |
$101M |
|
109M |
0.92 |
Neurocrine Biosciences
(NBIX)
|
2.9 |
$88M |
|
933k |
94.30 |
Vaxcyte
(PCVX)
|
2.8 |
$86M |
|
1.7M |
49.94 |
Alphatec Hldgs Note 0.750% 8/0 (Principal)
|
2.7 |
$82M |
|
71M |
1.16 |
Align Technology
(ALGN)
|
2.6 |
$79M |
|
224k |
353.64 |
Glaukos
(GKOS)
|
2.4 |
$74M |
|
1.0M |
71.21 |
Xenon Pharmaceuticals
(XENE)
|
2.3 |
$70M |
|
1.8M |
38.50 |
Natera
(NTRA)
|
1.8 |
$56M |
|
1.2M |
48.66 |
Deciphera Pharmaceuticals
(DCPH)
|
1.7 |
$51M |
|
3.6M |
14.08 |
Travere Therapeutics Note 2.500% 9/1 (Principal)
|
1.7 |
$51M |
|
56M |
0.90 |
Nuvasive Note 0.375% 3/1 (Principal)
|
1.6 |
$50M |
|
55M |
0.91 |
Ionis Pharmaceuticals Note 4/0 (Principal)
|
1.6 |
$50M |
|
53M |
0.95 |
Irhythm Technologies
(IRTC)
|
1.6 |
$50M |
|
479k |
104.32 |
Dice Therapeutics
|
1.6 |
$48M |
|
1.0M |
46.46 |
Keros Therapeutics
(KROS)
|
1.5 |
$46M |
|
1.1M |
40.18 |
Nevro
(NVRO)
|
1.5 |
$45M |
|
1.8M |
25.42 |
Karyopharm Therapeutics Note 3.000%10/1 (Principal)
|
1.4 |
$43M |
|
66M |
0.65 |
Intuitive Surgical Com New
(ISRG)
|
1.4 |
$42M |
|
124k |
341.94 |
Merus N V
(MRUS)
|
1.3 |
$41M |
|
1.5M |
26.33 |
Day One Biopharmaceuticals I
(DAWN)
|
1.3 |
$40M |
|
3.4M |
11.94 |
Boston Scientific Corporation
(BSX)
|
1.3 |
$39M |
|
717k |
54.09 |
Bridgebio Pharma Note 2.250% 2/0 (Principal)
|
1.3 |
$39M |
|
62M |
0.62 |
Legend Biotech Corp Sponsored Ads
(LEGN)
|
1.3 |
$38M |
|
556k |
69.03 |
Insmed Note 1.750% 1/1 (Principal)
|
1.2 |
$38M |
|
40M |
0.95 |
Paragon 28
(FNA)
|
1.2 |
$38M |
|
2.1M |
17.74 |
Neogenomics Note 0.250% 1/1 (Principal)
|
1.2 |
$36M |
|
49M |
0.74 |
Biogen Idec
(BIIB)
|
1.1 |
$35M |
|
122k |
284.85 |
Orthopediatrics Corp.
(KIDS)
|
1.1 |
$33M |
|
761k |
43.85 |
Outset Med
(OM)
|
1.0 |
$32M |
|
1.5M |
21.87 |
Aclaris Therapeutics
(ACRS)
|
1.0 |
$30M |
|
2.9M |
10.37 |
Axonics Modulation Technolog
(AXNX)
|
0.9 |
$29M |
|
574k |
50.47 |
Miragen Therapeutics
(VRDN)
|
0.9 |
$29M |
|
1.2M |
23.79 |
Krystal Biotech
(KRYS)
|
0.9 |
$28M |
|
241k |
117.40 |
Immunocore Hldgs Ads
(IMCR)
|
0.9 |
$28M |
|
468k |
59.96 |
Harrow Health
(HROW)
|
0.9 |
$28M |
|
1.5M |
19.04 |
Neogenomics Note 1.250% 5/0 (Principal)
|
0.9 |
$26M |
|
28M |
0.94 |
Amyris Note 1.500%11/1 (Principal)
|
0.9 |
$26M |
|
138M |
0.19 |
Alector
(ALEC)
|
0.8 |
$25M |
|
4.1M |
6.01 |
Anaptysbio Inc Common
(ANAB)
|
0.8 |
$24M |
|
1.2M |
20.34 |
Dbv Technologies S A Sponsored Adr
(DBVT)
|
0.8 |
$23M |
|
12M |
1.90 |
Travere Therapeutics Note 2.250% 3/0 (Principal)
|
0.7 |
$23M |
|
28M |
0.80 |
Penumbra
(PEN)
|
0.7 |
$23M |
|
66k |
344.06 |
Illumina Note 8/1 (Principal)
|
0.7 |
$23M |
|
23M |
1.00 |
Maravai Lifesciences Hldgs I Com Cl A
(MRVI)
|
0.7 |
$22M |
|
1.8M |
12.43 |
Enanta Pharmaceuticals
(ENTA)
|
0.7 |
$22M |
|
1.0M |
21.40 |
Hillevax
(HLVX)
|
0.7 |
$22M |
|
1.2M |
17.19 |
Cullinan Oncology
(CGEM)
|
0.7 |
$21M |
|
1.9M |
10.76 |
BioCryst Pharmaceuticals
(BCRX)
|
0.6 |
$20M |
|
2.8M |
7.04 |
Compass Therapeutics
(CMPX)
|
0.6 |
$19M |
|
6.0M |
3.18 |
Rapt Therapeutics
(RAPT)
|
0.6 |
$18M |
|
984k |
18.70 |
Vir Biotechnology
(VIR)
|
0.6 |
$18M |
|
729k |
24.53 |
Terns Pharmaceuticals
(TERN)
|
0.5 |
$16M |
|
1.8M |
8.75 |
Dyne Therapeutics
(DYN)
|
0.5 |
$16M |
|
1.4M |
11.25 |
Invitae Corp Note 2.000% 9/0 (Principal)
|
0.5 |
$15M |
|
17M |
0.89 |
Thermo Fisher Scientific
(TMO)
|
0.5 |
$14M |
|
27k |
521.75 |
Rhythm Pharmaceuticals
(RYTM)
|
0.5 |
$14M |
|
843k |
16.49 |
Integra Lifesciences Hldgs C Note 0.500% 8/1 (Principal)
|
0.4 |
$13M |
|
15M |
0.92 |
Danaher Corporation
(DHR)
|
0.4 |
$13M |
|
55k |
240.00 |
Pulmonx Corp
(LUNG)
|
0.4 |
$13M |
|
999k |
13.11 |
Repligen Corporation
(RGEN)
|
0.4 |
$13M |
|
92k |
141.46 |
Crinetics Pharmaceuticals In
(CRNX)
|
0.4 |
$12M |
|
650k |
18.02 |
Replimune Group
(REPL)
|
0.4 |
$11M |
|
488k |
23.22 |
Acelyrin
(SLRN)
|
0.3 |
$11M |
|
500k |
20.90 |
Guardant Health
(GH)
|
0.3 |
$9.7M |
|
270k |
35.80 |
Alx Oncology Hldgs
(ALXO)
|
0.3 |
$9.4M |
|
1.2M |
7.51 |
Mineralys Therapeutics
(MLYS)
|
0.3 |
$9.4M |
|
550k |
17.05 |
Mirati Therapeutics
|
0.3 |
$8.7M |
|
241k |
36.13 |
Seagen
|
0.3 |
$8.2M |
|
43k |
192.46 |
Agenus Com New
(AGEN)
|
0.2 |
$7.5M |
|
4.7M |
1.60 |
Nuvation Bio Com Cl A
(NUVB)
|
0.2 |
$7.4M |
|
4.1M |
1.80 |
Cutera Note 2.250% 6/0 (Principal)
|
0.2 |
$7.2M |
|
12M |
0.63 |
Adaptive Biotechnologies Cor
(ADPT)
|
0.1 |
$4.4M |
|
649k |
6.71 |
Insmed Note 0.750% 6/0 (Principal)
|
0.1 |
$3.0M |
|
3.5M |
0.84 |
Esperion Therapeutics
(ESPR)
|
0.0 |
$1.2M |
|
896k |
1.39 |
Alphatec Hldgs Com New
(ATEC)
|
0.0 |
$457k |
|
25k |
17.98 |